EP1635821 - 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.05.2010 Database last updated on 15.03.2025 | Most recent event Tooltip | 19.10.2012 | Lapse of the patent in a contracting state New state(s): TR | published on 21.11.2012 [2012/47] | Applicant(s) | For all designated states ELAN PHARMACEUTICALS, INC. 800 Gateway Boulevard South San Francisco, CA 94080 / US | [2006/12] | Inventor(s) | 01 /
GAROFALO, Albert, W. 128 Adrian Avenue South San Francisco, CA 94080 / US | 02 /
TUNG, Jay, S. 224 Semeria Avenue Belmont, CA 94002 / US | 03 /
PLEISS, Michael, A. 848 Stella Court Sunnyvale, CA 94086 / US | 04 /
WU, Jing 524 Shorebird Circle, Unit 15204 Redwood City, CA 94065 / US | 05 /
WONE, David, W., G. 6170 Honeysuckle Drive Newark, CA 94560 / US | 06 /
GUINN, Ashley C. 1404 Ocean Park Boulevard Santa Monica, CA 90405 / US | 07 /
DRESSEN, Darren, B. 3110 Casa de Campo, 2 San Mateo, CA 94403 / US | 08 /
MARUGG, Jennifer 6305 Paso Los Ceritos San Jose, CA 95120 / US | 09 /
NEITZEL, Martin 316 Seaside Drive Pacifica, CA 94044 / US | [2006/20] |
Former [2006/12] | 01 /
GAROFALO, Albert, W. 128 Adrian Avenue South San Francisco, CA 94080 / US | ||
02 /
TUNG, Jay, S. 224 Semeria Avenue Belmont, CA 94002 / US | |||
03 /
PLEISS, Michael, A. 848 Stella Court Sunnyvale, CA 94086 / US | |||
04 /
WU, Jing 524 Shorebird Circle, Unit 15204 Redwood City, CA 94065 / US | |||
05 /
WONE, David, W., G. 6170 Honeysuckle Drive Newark, CA 94560 / US | |||
06 /
GUINN, Ashley C. 335 Talbot Avenue, Apt. 102 A Pacifica, CA 94044 / US | |||
07 /
DRESSEN, Darren, B. 3110 Casa de Campo, 2 San Mateo, CA 94403 / US | |||
08 /
MARUGG, Jennifer 2094 Carlton Avenue San Jose, CA 95124 / US | |||
09 /
NEITZEL, Martin 3048 Ponderosa Drive Concord, CA 94520 / US | Representative(s) | Wytenburg, Wilhelmus Johannes, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2009/36] | Wytenburg, Wilhelmus Johannes, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | ||
Former [2006/12] | Wytenburg, Wilhelmus Johannes, et al Mewburn Ellis LLP York House 23 Kingsway GB-London WC2B 6HP / GB | Application number, filing date | 04751178.7 | 30.04.2004 | [2006/12] | WO2004US13655 | Priority number, date | US20030467695P | 02.05.2003 Original published format: US 467695 P | US20030503652P | 17.09.2003 Original published format: US 503652 P | [2006/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004099155 | Date: | 18.11.2004 | Language: | EN | [2004/47] | Type: | A2 Application without search report | No.: | EP1635821 | Date: | 22.03.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.11.2004 takes the place of the publication of the European patent application. | [2006/12] | Type: | B1 Patent specification | No.: | EP1635821 | Date: | 08.07.2009 | Language: | EN | [2009/28] | Search report(s) | International search report - published on: | EP | 10.11.2005 | Classification | IPC: | A61K31/415, A61K31/4155, C07D231/40, A61P29/00 | [2006/12] | CPC: |
C07D401/12 (EP,US);
A61P1/04 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P15/06 (EP);
A61P17/02 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P29/00 (EP);
A61P31/04 (EP);
A61P43/00 (EP);
C07D231/16 (EP,US);
C07D231/40 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/12] | Extension states | AL | 24.11.2005 | HR | 24.11.2005 | LT | 24.11.2005 | LV | 24.11.2005 | MK | 24.11.2005 | Title | German: | 4-BROM-5-(2-CHLOR-BENZOYLAMINO)-1H-PYRAZOL-3-CARBONSÄURE(PHENYL)AMID-DERIVATE UND VERWANDTE VERBINDUNGEN ALS BRADYKININ B1 RECEPTOR ANTAGONISTEN ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN | [2006/12] | English: | 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | [2006/12] | French: | DERIVES PHENYLAMIDE DU 4-BROMO-5-(3-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-ACIDE CARBOXYLIQUE ET COMPOSES SIMILAIRES POUR L'UTILISATION COMME ANTAGONISTS DU RECEPTEUR BRADYKININ B1 POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES | [2006/12] | Entry into regional phase | 24.11.2005 | National basic fee paid | 24.11.2005 | Designation fee(s) paid | 24.11.2005 | Examination fee paid | Examination procedure | 02.12.2004 | Request for preliminary examination filed International Preliminary Examining Authority: US | 24.11.2005 | Amendment by applicant (claims and/or description) | 24.11.2005 | Examination requested [2006/12] | 30.04.2007 | Despatch of a communication from the examining division (Time limit: M04) | 24.08.2007 | Reply to a communication from the examining division | 02.02.2009 | Communication of intention to grant the patent | 25.05.2009 | Fee for grant paid | 25.05.2009 | Fee for publishing/printing paid | Opposition(s) | 09.04.2010 | No opposition filed within time limit [2010/24] | Fees paid | Renewal fee | 30.03.2006 | Renewal fee patent year 03 | 11.04.2007 | Renewal fee patent year 04 | 25.03.2008 | Renewal fee patent year 05 | 16.04.2009 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 08.07.2009 | BE | 08.07.2009 | CY | 08.07.2009 | CZ | 08.07.2009 | DK | 08.07.2009 | EE | 08.07.2009 | FI | 08.07.2009 | IT | 08.07.2009 | NL | 08.07.2009 | PL | 08.07.2009 | RO | 08.07.2009 | SE | 08.07.2009 | SI | 08.07.2009 | SK | 08.07.2009 | TR | 08.07.2009 | BG | 08.10.2009 | GR | 09.10.2009 | ES | 19.10.2009 | PT | 09.11.2009 | HU | 09.01.2010 | [2012/47] |
Former [2012/42] | AT | 08.07.2009 | |
BE | 08.07.2009 | ||
CY | 08.07.2009 | ||
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
IT | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SE | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
GR | 09.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
HU | 09.01.2010 | ||
Former [2012/41] | AT | 08.07.2009 | |
BE | 08.07.2009 | ||
CY | 08.07.2009 | ||
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
IT | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SE | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
GR | 09.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2012/37] | AT | 08.07.2009 | |
BE | 08.07.2009 | ||
CY | 08.07.2009 | ||
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
IT | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
GR | 09.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2011/15] | AT | 08.07.2009 | |
BE | 08.07.2009 | ||
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
IT | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
GR | 09.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/50] | AT | 08.07.2009 | |
BE | 08.07.2009 | ||
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
GR | 09.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/25] | AT | 08.07.2009 | |
BE | 08.07.2009 | ||
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/23] | AT | 08.07.2009 | |
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SI | 08.07.2009 | ||
SK | 08.07.2009 | ||
BG | 08.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/22] | AT | 08.07.2009 | |
CZ | 08.07.2009 | ||
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
RO | 08.07.2009 | ||
SI | 08.07.2009 | ||
BG | 08.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/20] | AT | 08.07.2009 | |
DK | 08.07.2009 | ||
EE | 08.07.2009 | ||
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
SI | 08.07.2009 | ||
BG | 08.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/17] | AT | 08.07.2009 | |
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
SI | 08.07.2009 | ||
BG | 08.10.2009 | ||
ES | 19.10.2009 | ||
PT | 09.11.2009 | ||
Former [2010/10] | AT | 08.07.2009 | |
FI | 08.07.2009 | ||
NL | 08.07.2009 | ||
PL | 08.07.2009 | ||
SI | 08.07.2009 | ||
ES | 19.10.2009 | ||
Former [2009/51] | SI | 08.07.2009 | Cited in | International search | [A]DE3421386 (NATTERMANN A & CIE [DE]) [A] 1-13,15,17,18,20,21 * claim 1 * * page 4, line 33 *; | [X]WO9605196 (PHARMACIA SPA [IT], et al) [X] 1-13 * page 6 - page 18; compounds 1-81 * * example - * * claim - *; | [X]GB2310207 (PHARMACIA SPA [IT], et al) [X] 1-13,15,17,18,20,21 * page 14, line 27 * * example -; claim - *; | [X]WO9811101 (CANCER SOC AUCKLAND DIV NZ INC [NZ], et al) [X] 1-13 * examples S,T *; | [X]WO9927939 (US HEALTH [US], et al) [X] 1-13,15,17,18,20,21 * page 4, line 11 * * compound, page 8, line 9 * * claim 1 *; | [A]WO0050418 (FOURNIER IND & SANTE [FR], et al) [A] 1-23 * page 1, lines 10,11 * * claim 1 *; | [A]WO0187888 (SK CHEMICALS CO LTD [KR], et al) [A] 1-23 * page 3, lines 3,10,11 *; | [X]WO0202523 (PHARMACIA & UPJOHN SPA [IT], et al) [X] 1-13 * page 2 - page 3; compounds 1-7 * * compounds of formulae (I)-(V), (VII) *; | [X]WO0222655 (PHARMACIA & UPJOHN SPA [IT], et al) [X] 1-13 * compounds 3,9,10,14-18,21,22 * * claims 2,6,10,11,13 *; | [X]WO03015774 (ASTRAZENECA AB [SE], et al) [X] 1-13 * page 89; example GG5 * * claims 1,7,8,10 *; | [PX]WO03095429 (TRANSMIT TECHNOLOGIETRANSFER [DE], et al) [PX] 1-13 * page 13; example -; compound 1 * * page 17; example -; compounds 1,2 * * page 31; example 3 * * page 34; example 4 * * page 38; example 6 ** reference examples, pages 21-39 *; | [X] - BARALDI ET AL, "Benzoyl Nitrogen Mustard Derivatives of Benzoheterocyclic Analogues of Netropsin: Synthesis and Biological Activity", BIOORGANIC MEDICINAL CHEMISTRY, (20030410), vol. 11, page 2381-2388, XP002301176 [X] 1-13 * compound 3 * DOI: http://dx.doi.org/10.1016/S0968-0896(03)00144-5 | [X] - BARALDI ET AL, "Synthesis and Antitumor Activity of New Benzoheterocyclic Derivatives of Distamycin A", JOURNAL OF MEDICINAL CHEMISTRY, (2000), vol. 43, pages 2675 - 2684, XP002301177 [X] 1-13 * compounds 9,10 * DOI: http://dx.doi.org/10.1021/jm9911229 | [X] - BARALDI ET AL, "Novel Benzoyl Nitrogen Mustard Derivatives of Pyrazole Analogues of Distamycin A: Synthesis and Antileukemic Activity", BIOORGANIC AND MEDICINAL CHEMISTRY, (1999), vol. 7, pages 251 - 262, XP002301178 [X] 1-13 * compounds 3-11, 23-35, 38-40 * DOI: http://dx.doi.org/10.1016/S0968-0896(98)00205-3 | [X] - BARALDI ET AL, "Structure-Activity Relationship of Novel Tallimustine Derivatives: Synthesis and Antitumor Activity", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (1996), vol. 6, no. 11, pages 1247 - 1252, XP002301179 [X] 1-13 * compounds 1,2,10,11,12,14,16 * DOI: http://dx.doi.org/10.1016/0960-894X(96)00205-3 | [X] - BARALDI ET AL, "Synthesis and Antitumor Activity of Novel Distamycin Derivatives", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (1996), vol. 6, no. 11, pages 1241 - 1246, XP002301246 [X] 1-13 * compounds 1-4, 10, 13, * DOI: http://dx.doi.org/10.1016/0960-894X(96)00204-1 | [X] - ATWELL ET AL, "5-Amino-1-(chloromethyl)-1,2-dihydro-3H-benz[eindoles:", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1999), vol. 42, no. 17, ISSN 0022-2623, pages 3400 - 3411, XP002294767 [X] 1-13 * page 3402; compound D * * page 3403; compounds 33, 34 * DOI: http://dx.doi.org/10.1021/jm990136b | [X] - MARCHINI, S. ET AL, "Sequence-specific DNA alkylation of novel tallimustine derivatives", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (1998), Database accession no. 1998:302076, URL: STN, XP002301180 [X] 1-13 * abstract * | [ ] - ANTI-CANCER DRUG DESIGN, (1998), vol. 13, no. 3, pages 193 - 205 | [X] - LEE, H. H. ET AL, "Pyrazole analogs of the bispyrrolecarboxamide anti-tumor antibiotics: synthesis, DNA binding and anti-tumor properties", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (1992), Database accession no. 1992:173857, URL: STN, XP002301181 [X] 1-13 * abstract * | [ ] - ANTI-CANCER DRUG DESIGN, (1991), vol. 6, no. 5, pages 501 - 517 | [X] - ABDALLAH, MAGDA A. ET AL, "A convenient synthesis of 5-amino-4-(2-benzothiazolyl)pyrazoles", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (1998), Database accession no. 1998:233560, URL: STN, XP002301226 [X] 1-13 * abstract * | [ ] - INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, (1997), vol. 36, no. 12, pages 1175 - 1177 |